Sprycel 20 mg

SPRYCEL 20 MG tablets contain dasatinib, a medication used to treat certain types of cancer. This oral tablet is manufactured by Bristol-Myers Squibb Canada and is available in a 60-tablet pack.

SPRYCEL 20 MG tablets are primarily used in the treatment of specific types of cancer. Dasatinib, the active ingredient, is often prescribed for conditions where targeted therapy is required. Patients may wonder, 'What is dasatinib used for?' It is generally used in the management of chronic myeloid leukemia and acute lymphoblastic leukemia, among other indications.

Common effects of SPRYCEL 20 MG tablets may include fatigue, nausea, and skin rash. Some users might experience mild to moderate gastrointestinal discomfort. It is important to note that individual responses to dasatinib can vary, and not everyone will experience these effects.

SPRYCEL 20 MG tablets should be handled with care and stored as directed. Patients should follow their healthcare provider's instructions regarding administration and storage. It is crucial to inform your healthcare provider about any pre-existing conditions or allergies before starting dasatinib.

Dasatinib may interact with certain medications, including those metabolized by the liver's cytochrome P450 system. Patients should avoid grapefruit products, as they can affect dasatinib levels. Always consult a healthcare provider before combining dasatinib with other medications or supplements.